Larry Culpepper, MD: The Challenge of Treating BPD

Video

Borderline personality disorder remains one of the most difficult to understand conditions in psychiatry.

Borderline personality disorder (BPD) remains one of the most challenging and misunderstood disorders in psychiatry.

The disease is often diagnosed when the individual is a young adult, but psychiatrists often have to build trust with the patient over several months in order to really start seeing progress.

And that trust is ultimately hard to build.

During the 2022 Annual Psychiatric Times™ World CME Conference in San Diego on August 11, Larry Culpepper, MD, founding Chairman of the Department of Family Medicine at Boston University discussed studying borderline personality disorder more and how to best care for patients.

In an interview with HCPLive®, Culpepper explained why the disease can be so challenging and what psychiatrists must do to build that needed trust.

But most of all what is needed is more research into the disease.

“We don’t understand it,” Culpepper said. “We don’t understand its origins and how it developed in the individual. We don’t understand the issues for the patient that play out in their borderline personality disorder responses to the world.”

However, even with that said, Culpepper said psychiatrists do have the ability to make a positive impact in the patient’s life, mainly by promoting the correct course of therapy.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.